Lycera Obtains $5,000,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=35422332-4b50-4b18-8c73-c731e9b5af56 - Date
10/22/2013 - Company Name
Lycera - Mailing Address
2800 Plymouth Rd Ann Arbor, MI 48109 - Company Description
Lycera is an early-stage pharmaceutical company developing first-in-class drugs to treat immune disorders. Lycera’s technology platforms include proprietary small molecules that modulate a target, which is central to cellular bioenergetics along with molecules that target the Th17 pathway. - Website
http://www.lycera.com - Transaction Type
Debt - Transaction Amount
$5,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for any additional information, including solicitation if applicable. - M&A Terms
- Venture Investor
Undisclosed
